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Among several tyrosine-protein kinases, only v-abl could abrogate interleukin 3 dependence of a lympho-
blastoid cell line; v-src and v-fps proteins gave partial or no interleukin 3 independence, respectively.
Lymphokine independence was achieved via a nonautocrine mechanism. Direct involvement of c-myc in this
process was not evident.
Nonlymphoid hemopoietic cells infected with Abelson
murine leukemia virus (A-MuLV) have been reported to lose
their requirement for interleukin 3 (IL-3) for growth in vitro
(2, 6, 8). Lymphoid cells are the usual target of A-MuLV in
vivo (10). We have extended our knowledge from earlier
observations to an IL-3-dependent, lymphoid precursor cell
line, Ba/F3, and have compared the abilities of different
viruses encoding tyrosine-protein kinases to affect the IL-3
requirement of Ba/F3 cells. In addition, we have examined
the role of c-myc gene regulation in this process.
Clone Ba/F3 was derived from murine bone marrow. Like
similar clones, it expresses B-cell-specific surface glycopro-
tein B220 but has unrearranged immunoglobulin genes. It
lacks T-cell (Thyl, Lyt), myeloid (MAC-1, Ia), and mature
B-cell (Ig, Ia) antigens and strictly requires IL-3 for growth
in vitro (7).
We infected Ba/F3 cells with A-MuLV, helper Moloney
murine leukemia virus (Mo-MuLV), or an A-MuLV deriva-
tive (V-SAB) in which A-MuLV gag sequences have been
replaced with a 5' fragment of the src gene (4). Cells were
grown for 3 days in RPMI medium-10% fetal calf
serum-10% WEHI-3 conditioned medium (as a source of
IL-3) (7) and then were transferred to medium lacking IL-3.
Uninfected and Mo-MuLV-infected cells died within 48 h
without IL-3 supplementation. In contrast, 0.1% of the cells
treated with A-MuLV or V-SAB viruses survived. Mass
cultures were obtained within 2 weeks, and single cell clones
were derived. The low percentage of IL-3-independent cells
after A-MuLV or V-SAB infection reflects their poor infect-
ibility. When Ba/F3 cells were infected with the zip-neo
retrovirus, which confers G418 resistance (1), only 0.1% of
the cells survived G418 selection in IL-3-containing medium.
IL-3-independent cell clones expressed the transforming
protein ofA-MuLV or V-SAB viruses detected by an in vitro
kinase assay (Fig. 1A, lanes b and c). For this experiment,
extracts of infected clones were immunoprecipitated with
specific antisera, incubated with [-y-32P]ATP, and electro-
phoresed through polyacrylamide gels. Because of residual
nucleic acids in the extract, P160gag-abl appeared as a diffuse
band near the top of the gel (Fig. 1A, lane b). This was also
observed with different cell types infected with A-MuLV
(data not shown).
Because v-abl belongs to the protein-tyrosine kinase
oncogene family (12, 13), we tested the effects of other
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members on the IL-3 requirement of Ba/F3 cells. V-SRC,
V-GASRC, and V-GFPS recombinant viruses carry the src
gene in a Mo-MuLV vector (V-SRC) or part of the src orfps
genes fused to gag of A-MuLV (V-GASRC and V-GFPS,
respectively) (4).
Infections with viruses Mo-MuLV and A-MuLV were
carried out in parallel. Two days after the removal of IL-3
from medium, no surviving cells were observed in the
cultures infected with Mo-MULV or V-GFPS. By contrast,
equal numbers of surviving cells were detected in the A-
MuLV, V-SRC, and V-GASRC cultures, whereas clones of
A-MuLV-infected cells rapidly divided in the absence of
IL-3. Clones of V-SRC- and V-GASRC-infected cells grew
very poorly and appeared unhealthy. Rapid proliferation was
achieved only after adding back a small amount of IL-3. All
single cell clones derived from cultures infected with V-SRC
and V-GASRC expressed p60src and P78gag-rc, respectively
(Fig. 1B, lanes b and c; additional data not shown).
[35S]methionine labeling showed that these proteins were
expressed at levels similar to those of pl60gag-abl (data not
shown).
To allow selection of cells infected with a v-fps-containing
virus, we inserted the coding sequence of V-GFPS into the
DOL vector (provided by A. Korman) upstream of the neo
gene driven by a simian virus 40 promoter. The resulting
construct, pV-GFOL, was cotransfected with Mo-MuLV
DNA onto NIH 3T3 cells, and foci were isolated in the
presence of G418. Recovered virus from the best producer
clone was used to infect Ba/F3 cells. After G418 selection in
the presence of IL-3, some of the resistant cells were grown
in the absence of IL-3. These cells died within 2 days. Cells
from the same culture kept in IL-3 expressed P125gag-fps,
albeit at a lower level than in the V-GFOL producer NIH
3T3 clone (Fig. 1C, lanes b and c). Although P125gag-fps
expression is usually low in fibroblasts infected with V-
GFOL virus, 5 to 10% of infected cells expressed high levels
of the transforming protein (Fig. 1C, lane b; additional data
not shown). To attempt selection for high expression of
P125gag-fps in V-GFOL-infected Ba/F3 cells, we grew them
without IL-3 for enough time periods to kill the majority of
cells. After allowing the recovery of surviving cells in IL-3,
we measured expression of P125gag-fPs and the IL-3 require-
ment of the cells. In two separate experiments, the recov-
ered population behaved like the parental culture (data not
shown). Thus, the v-fps oncogene, in contrast to v-abl and
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FIG. 1. In vitro kinase assay of immunoprecipitated viral pro-
teins. Extracts of uninfected, v-abl-, v-src-, and v-fps-infected
Ba/F3 clones were immunoprecipitated with the indicated antisera,
and kinase activity was assayed as previously described (5). (A)
Anti-abl 587 antiserum (11); lanes: a, Ba/F3; b, A-MuLV Ba/F3; c,
V-SAB Ba/F3. (B) Anti-Rous sarcoma virus, TBR antiserum (v-src
specific) (lanes a and b) and anti-MuLV antiserum (lane c); lanes: a,
Ba/F3; b, V-SRC Ba/F3 (only phosphorylation of the immunoglob-
ulin heavy chain by p603-src was observed with tumor-bearing rabbit
antiserum); c, V-GASRV Ba/F3. (C) Anti-MuLV antiserum; lanes:
a, Ba/F3; b, V-GFOL NIH 3T3; c, V-GFOL Ba/F3. Panels A, B,
and C represent different gels.
v-src, did not provide any growth advantage to Ba/F3 cells in
the absence of IL-3 (Table 1).
As an illustration of the differences in uninfected and
A-MuLV-, V-SRC-, and V-GFOL-infected Ba/F3 cells, we
titrated their IL-3 requirements. Cell proliferation was mon-
itored by colorimetric assay (5) after a 24-h incubation (Fig.
2). A-MuLV-infected cells were totally IL-3 independent for
growth. V-SRC-infected cell clones displayed an intermedi-
ate proliferation profile. V-GFOL-infected cells behaved
similarly to uninfected cells (they were assayed in a separate
experiment). These results are consistent with earlier obser-
vations (Table 1).
The mechanisms by which A-MuLV confers IL-3 indepen-
dence remain uncertain. In agreement with other reports (2,
6, 8), we could rule out autocrine stimulation in virus-
TABLE 1. IL-3 requirement of Ba/F3 cells after viral infectiona
Virusb Transforming Titer' Transforming IL-3gene protein independence
Mo-MuLV __d 1 X 107 - No
A-MuLV v-abl 1 x 106 p16,gag-abl Total
V-SAB v-abl 1 x 106 P72src-abl Total
V-SRC v-src 5 x 105 p60sre Partial
V-GASRC v-Asrc 5 x 106 p7g8ag-Asrc Partial
V-GFPS v-fps S x 105 P125gag-fps No
Zip-neoe 1 x 106 No
V-GFOLe v-fps s x 104 P125gag-fps No
a Ba/F3 cells (106) were suspended in 3 ml of growth medium containing
10%0o of WEHI-conditioned medium. Virus (1 ml) was added to infect cultures.
Cells were incubated at 37'C overnight, washed, and replated in 10 ml of
growth medium containing 10%o WEHI-conditioned medium. After 24 h, cells
were washed twice and suspended in 10 ml of growth medium without a
source of IL-3. Medium was changed every 3 days, and cells were kept at a
density of at least 5 x 103/ml.
b All replication-defective viruses were pseudotyped with Mo-MuLV.
c Titers were measured on NIH 3T3 or XC cells. They are expressed as
PFU, focus-forming units, or G418 CFU per milliliter.
d_, None.
e For viruses containing the neo gene, the same infection protocol was used,
but G418 selection was applied first (1.5 mg of G418 per ml), in the presence
of IL-3.
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FIG. 2. Proliferation assay. Uninfected or virus-infected Ba/F3
cells (104 cells per well) were cultured for 24 h with IL-3 at the
indicated dilutions of a stock solution. Proliferation was then
measured in a colorimetric assay as previously described (5).
Measurements have been normalized by dividing the optical density
at a given IL-3 dilution by the density obtained at a 10-3 dilution of
IL-3.
infected cells. Poly(A)-containing RNA (2 ,ug) from infected
and uninfected Ba/F3 cells and WEHI cells was electropho-
resed, transferred to nitrocellulose, and hybridized to an
IL-3 specific probe (Fig. 3). Only WEHI cells expressed the
1-kilobase IL-3 mRNA (lane b) (14). Thus, IL-3 indepen-
dence in infected Ba/F3 cells did not result from endogenous
synthesis of IL-3. Furthermore, neither conditioned medium
nor freeze-thaw lysates from A-MuLV infectants supported
growth of uninfected Ba/F3 cells (data not shown). In
addition, we found the majority of IL-3 receptors in infected
cells available for binding and not occupied by a virus-
induced growth factor that could compete for the IL-3
receptor (data not shown).
v-abl might relieve IL-3 dependence of Ba/F3 cells by
inducing differentiation, presumably along the B-cell lineage.
a b c d
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FIG. 3. Absence of IL-3 mRNA in V-SRC- or A-MuLV-infected
Ba/F3. Glyoxal-treated, poly(A)-containing RNA (4 ,ug) were elec-
trophoresed through a 1% agarose gel, transferred to nitrocellulose,
and hybridized to an IL-3 cDNA probe. Lanes: a, Ba/F3; b, WEHI;
c, V-SRC Ba/F3; d, A-MuLV Ba/F3.
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FIG. 4. Effect of IL-3 or A-MuLV infection on c-myc mRNA in
BA/F3 cells. Total RNA was isolated from uninfected or A-MuLV-
infected BaIF3 cells at the indicated times after IL-3 addition. For
each time point, 20 pg of RNA was treated with glyoxal, electro-
phoresed through a 1% agarose gel, transferred to nitrocellulose,
and hybridized to a mouse c-myc cDNA probe. Rehybridizing the
blot with a ,2-microglobulin probe revealed an equal amount of
RNA in each lane (not shown). Migration of 28S and 18S rRNA is
shown. Lanes at hours indicated: a, 0; b, 1; c, 2; d, 6; e, 24.
No evidence of immunoglobulin heavy-chain rearrangement
was detected (3), however, in DNA from v-abl-infected
clones (data not shown).
Transformation by a virus expressing v-myc alleviated
IL-2 or IL-3 requirements in lymphokine-dependent cultured
cells (9). To examine whether IL-3 independence is achieved
by v-abl via c-myc deregulation, we studied regulation of
c-myc expression in uninfected and A-MuLV-infected Ba/F3
cells. Cultures were maintained for 12 h in the absence of
IL-3 (more than 75% of cells were still alive at that time).
IL-3 was then added, total RNA was isolated at various time
points, and c-myc transcripts were analyzed by Northern
hybridization (Fig. 4). In the absence of IL-3, no c-myc
transcription was detected in the nonproliferating,
uninfected cells. Addition of IL-3 caused a transient increase
in c-myc RNA that leveled off with time. In infected cells,
IL-3 caused a small increase in c-myc RNA, after a time
course similar to that seen for uninfected cells. In IL-3-
deprived, A-MuLV-infected cells, we detected a low level of
c-myc RNA. This increase may reflect v-abl action on c-myc
expression or cell proliferation. Thus, c-myc RNA levels
respond to A-MuLV infection and to IL-3 in Ba/F3 cells, but
this response could not be directly uncoupled from prolifer-
ation. Other investigators have shown that v-myc-infected,
IL-3-independent cells do not have detectable levels of
c-myc RNA (9), suggesting that the presence of the v-myc
protein could substitute for c-myc in growth. We do not have
direct evidence that v-abl causes IL-3 independence via a
specific increase in the c-myc message, although we cannot
rule it out.
That v-abl acts on a wide range of IL-3-dependent,
hemopoietic cells is well documented (2, 6, 8). v-abl must act
on a common denominator shared by these cells, possibly by
subverting the same pathway used by IL-3. It is therefore
important to address the substrate specificity of v-abl protein
among tyrosine kinases as a key to unlocking the cellular
events leading to IL-3 independence.
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